PHI Group Inc

PHI Group partners with Tenpoint Therapeutics to launch a direct‑to‑patient cash program for YUVEZZI™ presbyopia therapy, enhancing patient access to cutting‑edge vision care.

Canaccord Genuity Wealth Limited’s fresh stake in PHI Group Inc. signals positive momentum, reshaping its growth strategy and investor outlook in the financial services sector.

PHI Group Inc. delivers niche financial advisory and project financing services across North America and Asia, focusing on operational efficiency and organic growth despite a modest market cap.

PHI Group Inc. shows a narrow trading range, negative price‑earnings, and a low market cap, raising doubts about its growth and profitability in financial services.

PHI Group Inc. faces stagnant growth and low liquidity while offering M&A, consulting, and financing services across North America and Asia. Find out why investors remain cautious.

PHI Group Inc.

PHI Group Inc.

PHI Group Inc. offers diversified financial services—M&A advisory, financing, and capital markets—highlighting its resilience, strategic growth, and niche market position.